UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

492 PLATELET RICH STROMA DURING SURGERY FOR TREATMENTREFRACTORY PERIANAL FISUTLIZING CROHN'S DISEASE: LONG-TERM OUTCOMES OF A PILOT STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-114-S-114

2024

Volltextzugriff (PDF)

Su1839 IDENTIFICATION OF CLINICAL RISK FACTORS FOR POSTOPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE: A PROSPECTIVE, MULTICENTER COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-837-S-838

2024

Volltextzugriff (PDF)

Modulation of cytokine patterns and microbiome during pregnancy in IBD

Gut, 2020-03, Vol.69 (3), p.473-486

2020

Volltextzugriff (PDF)

The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies

The American journal of gastroenterology, 2016-09, Vol.111 (9), p.1305-1312

2016

Volltextzugriff (PDF)

Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice

Journal of gastroenterology and hepatology, 2020-11, Vol.35 (11), p.1893-1901

2020

Volltextzugriff (PDF)

Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial

Clinical gastroenterology and hepatology, 2022-09, Vol.20 (9), p.2074-2082

2022

Volltextzugriff (PDF)

No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis

Clinical gastroenterology and hepatology, 2020-07, Vol.18 (8), p.1777-1784.e2

2020

Volltextzugriff (PDF)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study

BMJ open, 2022-04, Vol.12 (4), p.e058358-e058358

2022

Volltextzugriff (PDF)

The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review

Inflammatory bowel diseases, 2021-04, Vol.27 (5), p.711-724

2021

Volltextzugriff (PDF)

Mo1804 - Predictors of Persistent Fatigue in Patients with Inflammatory Bowel Disease in Biologic-Induced Clinical Remission

Gastroenterology (New York, N.Y. 1943), 2018-05, Vol.154 (6), p.S-807-S-807

2018

Volltextzugriff (PDF)

27 LONGITUDINAL TRAJECTORY OF FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: A PROSPECTIVE STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-10-S-10

2020

Volltextzugriff (PDF)

Tu1164 POST-COVID GENERAL HEALTH SYMPTOMS IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1265-S-1266

2024

Volltextzugriff (PDF)

1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-220-S-220

2023

Volltextzugriff (PDF)

Tu1818 POSTOPERATIVE PROPHYLAXIS PREVENTS SURGICAL AND SEVERE ENDOSCOPIC RECURRENCE AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1420-S-1421

2024

Volltextzugriff (PDF)

Mo1770 INTEROBSERVER AGREEMENT OF CURRENT AND NEW PROPOSED ENDOSCOPIC SCORES FOR POSTOPERATIVE RECURRENCE IN CROHN'S DISEASE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1105-S-1105

2024

Volltextzugriff (PDF)

Mo1887 – Ustekinumab Endoscopic Response At Week 16 is Associated with Early Normalization of Fecal Calprotectin After Induction

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-874-S-875

2019

Volltextzugriff (PDF)

537 – Fecal Calprotectin is an Early Predictor of Endoscopic Response and Histological Remission After the Start of Vedolizumab

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-110-S-110

2019

Volltextzugriff (PDF)

Sa1871 – High Infliximab Trough Levels Have No Impact on Fatigue in IBD Patients in Endoscopic Remission: A Prospective Cohort Study

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-436-S-437

2019

Volltextzugriff (PDF)

Su1797 THE COLLECTION OF THE PATIENT-REPORTED OUTCOMES INCLUDED IN THE CORE DATA SET FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PRACTICAL RECOMMENDATIONS

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-687-S-687

2023

Volltextzugriff (PDF)

411 PLATELET-RICH STROMA INJECTION (PRS) AS A NOVEL SURGICAL TREATMENT FOR TREATMENT-REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE: A PILOT STUDY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-82-S-83

2021

Volltextzugriff (PDF)

Su434 A POPULATION PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF VEDOLIZUMAB TO TARGET ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN'S DISEASE: POST HOC ANALYSIS OF THE LOVE-CD STUDY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-687-S-688

2021

Volltextzugriff (PDF)

Tu1790 - Pregnancy in IBD: Direct Effect of Sex-Hormones on Epithelial Barrier Function

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S969-S969

2017

Volltextzugriff (PDF)

Pregnancy in IBD: Direct Effect of Sex-Hormones on Epithelial Barrier Function

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S969

2017

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(68)

Sprache

Englisch
(68)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

492 PLATELET RICH STROMA DURING SURGERY FOR TREATMENTREFRACTORY PERIANAL FISUTLIZING CROHN'S DISEASE: LONG-TERM OUTCOMES OF A PILOT STUDY

Su1839 IDENTIFICATION OF CLINICAL RISK FACTORS FOR POSTOPERATIVE ENDOSCOPIC RECURRENCE IN CROHN'S DISEASE: A PROSPECTIVE, MULTICENTER COHORT STUDY

Modulation of cytokine patterns and microbiome during pregnancy in IBD

The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies

Fecal calprotectin is a reliable marker of endoscopic response to vedolizumab therapy: A simple algorithm for clinical practice

Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX Trial

No Superiority of Tacrolimus Suppositories vs Beclomethasone Suppositories in a Randomized Trial of Patients With Refractory Ulcerative Proctitis

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study

The Effect of Psychotherapy on Quality of Life in IBD Patients: A Systematic Review

Mo1804 - Predictors of Persistent Fatigue in Patients with Inflammatory Bowel Disease in Biologic-Induced Clinical Remission

27 LONGITUDINAL TRAJECTORY OF FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS: A PROSPECTIVE STUDY

Tu1164 POST-COVID GENERAL HEALTH SYMPTOMS IN PATIENTS WITH IMMUNE MEDIATED INFLAMMATORY DISEASES

1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL

Tu1818 POSTOPERATIVE PROPHYLAXIS PREVENTS SURGICAL AND SEVERE ENDOSCOPIC RECURRENCE AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE

Mo1804 IMAGING-BASED PREOPERATIVE BODY COMPOSITION IS ASSOCIATED WITH THE RISK OF POSTOPERATIVE COMPLICATIONS AND POSTOPERATIVE ENDOSCOPIC RECURRENCE IN PATIENTS WITH CROHN'S DISEASE

Mo1770 INTEROBSERVER AGREEMENT OF CURRENT AND NEW PROPOSED ENDOSCOPIC SCORES FOR POSTOPERATIVE RECURRENCE IN CROHN'S DISEASE

Mo1887 – Ustekinumab Endoscopic Response At Week 16 is Associated with Early Normalization of Fecal Calprotectin After Induction

537 – Fecal Calprotectin is an Early Predictor of Endoscopic Response and Histological Remission After the Start of Vedolizumab

Sa1871 – High Infliximab Trough Levels Have No Impact on Fatigue in IBD Patients in Endoscopic Remission: A Prospective Cohort Study

Su1797 THE COLLECTION OF THE PATIENT-REPORTED OUTCOMES INCLUDED IN THE CORE DATA SET FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: PRACTICAL RECOMMENDATIONS

Prophylactic Medication for the Prevention of Endoscopic Recurrence in Crohn's Disease: a Prospective Study Based on Clinical Risk Stratification

411 PLATELET-RICH STROMA INJECTION (PRS) AS A NOVEL SURGICAL TREATMENT FOR TREATMENT-REFRACTORY COMPLEX PERIANAL FISTULAS IN CROHN'S DISEASE: A PILOT STUDY

Su434 A POPULATION PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF VEDOLIZUMAB TO TARGET ENDOSCOPIC REMISSION IN PATIENTS WITH CROHN'S DISEASE: POST HOC ANALYSIS OF THE LOVE-CD STUDY

Tu1790 - Pregnancy in IBD: Direct Effect of Sex-Hormones on Epithelial Barrier Function

Pregnancy in IBD: Direct Effect of Sex-Hormones on Epithelial Barrier Function

Suchergebnisse filtern